![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.75 | 1.70 | 1.80 | 1.75 | 1.75 | 1.75 | 274,932 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.34 | 13.57M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/7/2019 08:25 | 20 trading days to go, tick tock! | ![]() ny boy | |
28/6/2019 16:46 | T+20s will come into play next week... | ![]() nobbygnome | |
28/6/2019 14:07 | Excitement mounting, only 20 trading days to go for a potential game changing event! | ![]() ny boy | |
28/6/2019 14:06 | Looking at some of the recent trades there seems to be a pattern of very tactical buying in reasonable bites around 20k. Is this a softly softly approach to avoid raising the share price? | maximus72 | |
28/6/2019 12:23 | Finally the big countdown month of July,starts on Monday! | ![]() ny boy | |
28/6/2019 11:13 | Why is it not showing as a ‘proper’ trade? | ![]() peachie 74 | |
28/6/2019 10:48 | Could that be a director buy? Hope so | ![]() wuzy | |
27/6/2019 16:08 | Off topic ...apologises to all who think posting about another share is a cardinal sin.....but apparently results of immupharmas open label stadycare out tomorrow ....according to poster on immu thread | ![]() kop202 | |
27/6/2019 13:11 | China was mentioned as being high up the agenda at the investor day a couple of months ago. Clearly there was no steer as to timelines but there is no doubt they are actively talking to partners. | ![]() nobbygnome | |
27/6/2019 12:24 | No not me if I bought that, would take me over 3% and would have to declare, lol Roll on 27th July. | ![]() montyhedge | |
27/6/2019 11:20 | Someone is keen, 20,000 @ 114p, was that you Monty? 🤔 | ![]() ny boy | |
27/6/2019 10:57 | They might want to space it out. | crankyman | |
27/6/2019 10:50 | Interesting to see f there is any FDA leaky news to a chosen few, it will certainly become apparent in the share price action as the shares are tightly held, stand by fir action stations next month! I don’t think any China news until Q4 earliest but is anyone in a hurry here. | ![]() ny boy | |
27/6/2019 10:45 | Thank you. Good to know ! | ![]() peachie 74 | |
27/6/2019 10:42 | A China deal would blow the top off £2.50 | crankyman | |
27/6/2019 10:38 | It's on page 3 and 14 of the annual report. They said they would conclude that this year. | crankyman | |
27/6/2019 09:40 | We obviously know of the US decision and have a date. Regards to China, is Ferracru definitely being looked at or is it speculation ? | ![]() peachie 74 | |
27/6/2019 08:18 | Two more inflection points coming: a US deal and a China deal. After that, it’s the numbers on Germany and U.K. uptake following the Norgine promotion and H2H data( not that that’s even out there yet - they need an abstract at least) | crankyman | |
26/6/2019 19:18 | Yes almost into T+20 range.... | ![]() nobbygnome | |
26/6/2019 18:39 | Curious was polite Expected a slight retrace after strong run but this is one I certainly will be fully in up to FDA decision . | ![]() best1467 | |
26/6/2019 17:46 | Tick tock, only 22 trading days left.. FDA starts to become the focus for investors now. I expect strong start of month buying on Monday onwards. Onwards & upwards! | ![]() ny boy | |
26/6/2019 17:36 | Curious post. Yes I guess it's not impossible if the FDA rejects Ferracru out of hand....but as we all know here that is extremely extremely unlikely! 150p in the short term is much more likely IMHO. | ![]() nobbygnome | |
26/6/2019 16:59 | ureckon 50pis on | ![]() andymunchkin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions